PWC
MRNA icon

PYA Waltman Capital’s Moderna MRNA Stock Holding History

PYA Waltman Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-81
Closed -$10K – 144
2022
Q3 		$10K Hold
81
– – 0.01% 139
2022
Q2 		$12K Hold
81
– – 0.01% 145
2022
Q1 		$14K Hold
81
– – 0.01% 137
2021
Q4 		$21K Buy
+81
New +$23.7K 0.01% 124

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PYA Waltman Capital's MRNA Position: Q4 2022 in Review

PYA Waltman Capital sold out of Moderna (MRNA) in Q4 2022, closing a stake of 81 shares — an estimated $10K sold.

PYA Waltman Capital first reported a position in MRNA in Q4 2021 and held it in 4 quarters. The position peaked at $21K in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • PYA Waltman Capital reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • PYA Waltman Capital sold 81 Moderna shares in Q4 2022, an estimated $10K.
  • PYA Waltman Capital first reported a position in Moderna in Q4 2021 and held it in 4 quarters.
  • PYA Waltman Capital's Moderna position peaked at $21K in Q4 2021.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on PYA Waltman Capital's 13F filing for Q4 2022, filed 14 Feb 2023.